{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Richland",
      "address_1": "199 Interstate Dr Ste N",
      "reason_for_recall": "CGMP Deviations; deficiencies at the manufacturer  may result in assay or content uniformity failures",
      "address_2": "",
      "product_quantity": "823 bottles",
      "code_info": "LOT # 29131501, EXP 9/17",
      "center_classification_date": "20161129",
      "distribution_pattern": "Nationwide",
      "state": "MS",
      "product_description": "UROPHEN MB URINARY ANTISEPTIC Tablets, Each tablet contains:  Methenamine 81.6 mg, Benzoic Acid 9.0 mg, Phenyl Salicylate 36 mg, Methylene Blue 10.8 mg, Hyoscyamine Sulfate 0.12 mg, 100 count bottles, Rx only, Manufactured for: BUREL PHARMACEUTICALS, Richland, MS --- NDC 35573-307-10",
      "report_date": "20161207",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "Burel Pharmaceuticals Inc",
      "recall_number": "D-0158-2017",
      "initial_firm_notification": "E-Mail",
      "product_type": "Drugs",
      "event_id": "75566",
      "termination_date": "20170814",
      "more_code_info": "",
      "recall_initiation_date": "20161024",
      "postal_code": "39218-9433",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}